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Background: Hydrocephalus following spontaneous aneurysmal sub-arachnoid hemorrhage (SAH) is often
associated with unfavorable outcome. This study aimed to determine the potential risk factors and outcomes of
shunt-dependent hydrocephalus in aneurysmal SAH patients but without hydrocephalus upon arrival at the
hospital.
Methods: One hundred and sixty-eight aneurysmal SAH patients were evaluated. Using functional scores, those
without hydrocephalus upon arrival at the hospital were compared to those already with hydrocephalus on
admission, those who developed it during hospitalization, and those who did not develop it throughout their
hospital stay. The Glasgow Coma Score, modified Fisher SAH grade, and World Federation of Neurosurgical
Societies grade were determined at the emergency room. Therapeutic outcomes immediately after discharge and
18 months after were assessed using the Glasgow Outcome Score.
Results: Hydrocephalus accounted for 61.9% (104/168) of all episodes, including 82 with initial hydrocephalus on
admission and 22 with subsequent hydrocephalus. Both the presence of intra-ventricular hemorrhage on admission
and post-operative intra-cerebral hemorrhage were independently associated with shunt-dependent hydrocephalus
in patients without hydrocephalus on admission. After a minimum 1.5 years of follow-up, the mean Glasgow
outcome score was 3.33 ± 1.40 for patients with shunt-dependent hydrocephalus and 4.21 ± 1.19 for those without.
Conclusions: The presence of intra-ventricular hemorrhage, lower mean Glasgow Coma Scale score, and higher
mean scores of the modified Fisher SAH and World Federation of Neurosurgical grading on admission imply risk of
shunt-dependent hydrocephalus in patients without initial hydrocephalus. These patients have worse short- and
long-term outcomes and longer hospitalization.
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Aneurysmal sub-arachnoid hemorrhage (SAH) still has
high mortality and morbidity rates despite modern
neurosurgical techniques, new powerful imaging moda-
lities, and care of such patients [1]. An important neuro-
logic complication is hydrocephalus [2–5], which can be
either acute-onset on admission or progressive during
the hospital stay [2–5]. The overall risk of hydrocephalus
after aneurysmal SAH varies between 6% to 67% in dif-
ferent series [6,7] although only 10-20% of them will
require permanent CSF diversion [6,7]. To date, no clin-
ical study has focused specifically on predicting shunt
dependency in patients with aneurysmal SAH but with-
out hydrocephalus upon arriving at the hospital, or the
outcome of these specific patients for a longer follow-up
period. Because of possible benefits of therapeutic inter-
vention, there is a need for better delineation of the po-
tential risk factors and clinical features in this specific
sub-group.
This study aimed to analyze the clinical features, neuro-
imaging findings, and clinical scores and measurements to
determine the potential risk factors predictive of shunt-
dependent hydrocephalus in patients with aneurysmal
SAH but without hydrocephalus upon arriving at the hos-
pital. The study also compared these patients to those with
hydrocephalus at the time of admission, those who deve-
loped it during hospitalization, and those who did not
develop it after 1.5 years of follow-up.Methods
Study design
From January 2003 to December 2005, 168 SAH patients
admitted to the Department of Neurosurgery at the
Chang Gung Memorial Hospital in Kaohsiung were en-
rolled. Chang Gung Memorial Hospital-Kaohsiung is a
2482-bed acute-care teaching hospital, which is the lar-
gest medical center in the southern part of Taiwan pro-
viding both primary and tertiary referral care to patients.
All patients received complete medical and neurologic
examinations, and brain computed tomography (CT)
with cerebral angiography. The Chang Gung Memorial
Hospital hospital’s Institutional Review Committee on
Human Research approved the study (Institutional Re-
view Board numbers: 96-1575B). Neurosurgeons and
neuro-radiologists integrated the clinical manifestations
and neuro-imaging findings.Diagnostic criteria of spontaneous aneurysmal
sub-arachnoid hemorrhage
All of the patients received brain CT scans soon after ar-
rival at the emergency room, and follow-up brain CT
post-surgery. Emergency brain CT scans were done if
there was clinical deterioration, including acute-onsetfocal neurologic deficits, seizures or status epilepticus,
or progressively disturbed consciousness and post-
neurosurgical procedures.
In the study hospital, it was routine practice to arrange
cerebral angiograms immediately after hospitalization. A
ruptured, angiographically verified aneurysm was the
cause of the SAH in all patients. Patients initially treated
in other hospitals but subsequently transferred for fur-
ther therapy were also included in the study and their
initial clinical and laboratory data at the previous hos-
pital were used for analysis. Patients were excluded if: 1)
the initial angiogram was negative for SAH; 2) they suf-
fered from non-aneurysmal SAH, such as traumatic
SAH; 3) they were comatose or were considered unlikely
to survive for more than one week; and 4) there were
pre-existing neurologic deficits.
Clinical assessment
Hydrocephalus was judged retrospectively by a dilated
temporal horn of the ventricle without obvious brain at-
rophy and/or an Evan’s ratio >0.3 on initial CT scan.
The Evan’s ratio was the ratio of the ventricular width of
the bilateral frontal horn to the maximum bi-parietal
diameter [8]. Furthermore, shunt-dependent hydroceph-
alus was defined as clinical symptoms of hydrocephalus
(i.e., decreased mental status, axial rigidity, and incontin-
ence) with radiographic evidence of enlarged ventricles
or high opening pressure on repeated lumbar punctures
requiring the insertion of a ventriculo-peritoneal (VP)
shunt [2,3].
The characteristics and circumstances, and complica-
tions following underlying SAH or treatment were
documented. The diagnosis of acute symptomatic cere-
bral infarction following aneurysmal SAH was based
on both new-onset cerebral infarctions (on follow-up
brain CT) and the presence of acute neurologic defi-
cits causally related to the cerebral infarction. Patients
were considered to have multiple infarctions if at least
two locations with infarctions were found. Re-bleeding
was defined as sudden deterioration of the clinical
state accompanied by new or increased blood on brain
CT scan [9]. Symptomatic vasospasm was defined as
both the development of focal neurologic signs or de-
terioration in conscious state and evidence of vaso-
spasm or presence of stenotic flow velocity shown by
trans-cranial color-coded sonography through cerebral
angiogram, CT angiography, or magnetic resonance
angiography [10,11]. All diagnoses of hydrocephalus,
re-bleeding, and vasospasm were based on brain CT
evidence.
The Glasgow Coma Score (GCS) [12], modified Fisher
SAH grade [13], and World Federation of Neurosurgical
Societies (WFNS) grade [14] were determined by neuro-
surgeons upon the patient’s arrival at the emergency
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ately after discharge and 18 months after used Glasgow
Outcome Score (GOS). The follow-up period was ter-
minated by death or by the end of the study (June
2007). The outpatient department followed-up most
patients after discharge as part of standard care, while
others were interviewed by telephone to identify neuro-
logic outcome.Statistical analysis
Three separate series of statistical analyses were per-
formed. First, to compare demographic data among
patients who already had hydrocephalus at the time of
admission, those who developed it during hospitalization
and those who did not have it during the hospital stay,
categorical variables were assessed by Chi-square test,
and continuous variables were logarithmically trans-
formed to improve normality and compared using one-
way ANOVA for parametric data, followed by Scheffe’s
multiple comparison for post-hoc test for significant
pairwise differences.
Second, risk factors of shunt-dependent hydrocephalus
in patients with aneurysmal SAH but without hydro-
cephalus upon arrival were analyzed. Baseline clinical
data, including gender, clinical manifestations, and
neuro-imaging findings between those with and those
without shunt-dependent hydrocephalus were analyzed
by Chi-square test or Fisher’s exact test, where appropri-
ate. The mean ages, mean systolic and diastolic pressure,
and mean hospitalization days between the two patient
groups were analyzed by Student’s t-test. The GCS at the
time of admission, GOS at the time of discharge and
18 months after discharge, mean modified Fisher SAH
grade, and mean WFNS grade between the two patient
groups were analyzed by the Wilcoxon rank sum test.
Lastly, stepwise logistic regression was used to evaluate the
relationships between clinical factors and the presence of
shunt-dependent hydrocephalus, with adjustments for other
potential confounding factors. All of the statistical analyses
was conducted using the SAS software package, version 9.1
(2002, SAS Statistical Institute, Cary, North Carolina).Results
Baseline characteristics of the study patients
Of the 168 aneurysmal SAH patients (52 males and 116
females), 104 had complications with hydrocephalus
during the acute phase, including initial hydrocephalus
in 82 and subsequent hydrocephalus in 22. Their charac-
teristics in terms of hydrocephalus and location and
seize of aneurysms were listed in Tables 1 and 2. Hyper-
tension, diabetes mellitus (DM), and coronary artery dis-
eases were the three most common underlying diseases.
The proportions of nosocomial pneumonia in patientswith initial hydrocephalus and subsequent hydroceph-
alus were 39% (32/82) and 50% (11/22), respectively.
The mean GCS on presentation were 10.88 ± 4.07,
11.64 ± 3.65, and 13.16 ± 2.96 for patients with initial
hydrocephalus, subsequent hydrocephalus, and no
hydrocephalus, respectively (p= 0.001). The mean modi-
fied Fisher SAH grade on presentation were 3.17 ± 0.86,
2.82 ± 0.96, and 2.42 ± 0.79, respectively (p < 0.0001),
while the mean WFNS grade on presentation were
2.95 ± 1.41, 2.86 ± 1.46, and 2.01 ± 1.20, respectively
(p < 0.0001). The median time (interquartile range) of
ventriculostomy insertion relative to the date of presen-
tation were 1 (0, 2) and 1.5 (0.25-6.25) days for patients
with initial hydrocephalus and subsequent hydroceph-
alus, respectively (p = 0.138, Mann–Whitney U test).Complications following aneurysmal SAH
Complications following underlying aneurysmal SAH
among the three patient groups were listed in Table 3.
The proportions of intra-ventricular hemorrhage were
51.2% (42/82), 27.2% (6/22), and 7.8% (5/64) in patients
with initial hydrocephalus, subsequent hydrocephalus,
and no hydrocephalus, respectively (p < 0.0001). The
proportions of hyponatremia were 12.2% (10/82), 22.7%
(5/22), and 3.1% (2/64), respectively (p= 0.022), while
the proportions of diabetes inspidus were 1.2% (1/82),
9% (2/22), and 0% (0/64), respectively (p= 0.018). Other
complications following the aneurysmal SAH included
cerebral infarctions, aneurysmal re-bleeding, vasospasm,
intra-cerebral hemorrhage, and arrhythmia (Table 2).
Complications following the treatment of aneurysmal
SAH were listed in Table 2. The proportions of nosoco-
mial pneumonia were 25.6% (21/82), 40.9% (9/22), and
6.3% (4/64) in patients with initial hydrocephalus, subse-
quent hydrocephalus, and no hydrocephalus, respectively
(p= 0.001), while the proportions of post-operative intra-
cerebral hemorrhage following surgical interventions
were 6.1% (5/82), 27.3% (6/22), and 6.3% (4/64), respect-
ively (p= 0.005). Complications related to ventriculo-
peritoneal (VP) shunt procedures included shunt infec-
tions, over-shunting and shunt obstructions (Table 2).
The mean lengths of hospitalization among the three
groups were 30.40 ± 21.97, 44.45 ± 24.34, and 20.03 ±
16.80 (p < 0.0001). Therapeutic outcomes among the
168 patients after discharge as determined by GOS were
36 normal (21.4%, 36/168), 64 moderate disability
(38.1%, 64/168), 24 severe disabilities (14.2%, 24/168), 24
persistent vegetative states (14.2%, 24/168), and 20 mor-
talities (11.9%, 20/168). The mean GOS score among the
three groups were 3.18 ± 1.34, 2.86 ± 0.91, and 3.97 ± 1.14
in patients with initial hydrocephalus, subsequent hydro-
cephalus, and no hydrocephalus, respectively (p < 0.0001).
After a 1.5-year follow-up, the mean GOS score among
Table 1 Characteristics of patients with aneurysmal SAH in terms of hydrocephalus (n =168)
With Hydrocephalus Without Hydrocephalus P value
Initial hydrocephalus Subsequent hydrocephalus
N=82 N=22 N=64
Mean age, years 57.79 ± 14.79 57.32 ± 11.59 52.59 ± 12.08 0.06
Sex (male/female) 29/53 7/15 16/48 0.403
Mean blood pressure on presentation
Systolic Blood pressure (mmHg) 148.07 ± 23.62 143.68 ± 24.29 145.73 ± 22.90 0.687
Diastolic Blood pressure (mmHg) 81.27 ± 13.93 79.13 ± 16.24 81.89 ± 11.87 0.712
Mean GCS on presentation 10.88 ± 4.07 11.64 ± 3.65 13.16 ± 2.96 0.001α
Mean modified Fisher SAH grade on presentation 3.17 ± 0.86 2.82 ± 0.96 2.42 ± 0.79 <0.0001β
Mean WFNS grade on presentation 2.95 ± 1.41 2.86 ± 1.46 2.01 ± 1.20 <0.0001γ
Mean Hospitalization days 30.40 ± 21.97 44.45 ± 24.34 20.03 ± 16.80 <0.0001E
Underlying diseases
Atrial fibrillation 2 0 1
Coronary artery diseases 3 3 3 0.174
Diabetes mellitus 8 3 4 06540
End-stage renal diseases 3 0 2 0.666
Hypertension 38 12 21 0.119
Treatmentθ
Clipping of aneurysm only 35 17 35
Transarterial embolization only 29 3 24
Both transarterial embolization and clipping 8 1 1
External ventral drainage 52 16 –
Ventriculoperitoneal shuntι 32 15 –
Mean GOS at discharge 3.18 ± 1.34 2.86 ± 0.91 3.97 ± 1.14 <0.0001η
Good recovery 12 0 24
Moderate disability 32 6 26
Severe disability 11 7 6
Vegetative state 13 7 4
Death 14 2 4
Mean GOS after more than 18 months of follow-up 3.70 ± 1.69 3.18 ± 1.26 4.36 ± 1.13 0.002θ
Abbreviations: SAH, sub-arachnoid hemorrhage; GCS, Glasgow Coma Scale; GOS, Glasgow Outcome Scale; WFNS, World Federation of Neurosurgical Societies; θ,
Not all patients have every treatment; –, not done; ι, Shunt-dependent hydrocephalus; IH, Initial hydrocephalus; SH, Subsequent hydrocephalus; WH, Without
Hydrocephalus.
Post-hoc test: α= IH vs. WH, p = 0.001; β= IH vs. WH, p < 0.0001; γ= IH vs. WH, p < 0.0001; SH vs. WH, p = 0.041; E= IH vs. SH, p = 0.019; IH vs. WH, p = 0.011; SH vs.
WH, p < 0.001; η= IH vs. WH, p = 0.001; SH vs. WH, p = 0.002; θ= IH vs. WH, p = 0.025; SH vs. WH, p = 0.005.
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4.36 ± 1.13, respectively (p= 0.002).
Risk factors of shunt-dependent hydrocephalus
Risk factors of shunt-dependent hydrocephalus in
patients with aneurysmal SAH but without hydroceph-
alus upon arrival at the hospital were listed in Table 4.
Statistical analysis revealed significant mean GCS on
presentation (p= 0.01), mean modified Fisher SAH
grade on presentation (p= 0.039), mean WFNS grade
on presentation (p= 0.012), presence of intra-ventricular
hemorrhage on admission (p < 0.003), and post-
operative intra-cerebral hemorrhage (p= 0.013). Thesevariables were then used in the stepwise logistic re-
gression model. After analysis, only the presence of
intra-ventricular hemorrhage on admission (p = 0.003,
OR = 9.608, 95% CI: 2.207-41.822) and post-operative
intra-cerebral hemorrhage (p = 0.011, OR= 7.354, 95%
CI: 1.576-34.313) were independently associated with
the presence of shunt-dependent hydrocephalus.
Discussion
To date, this is the first study to determine the potential
risk factors that are predictive of shunt-dependent hydro-
cephalus in patients with aneurysmal SAH but without
hydrocephalus upon arriving at the hospital. Differences in
Table 2 Location and seize of aneurysms in patients in terms of hydrocephalus (n = 168)
With Hydrocephalus Without Hydrocephalus Total
Initial hydrocephalus Subsequent hydrocephalus
N=82 N=22 N=64 N=168
Location of aneurysm
Single (n = 156)
Anterior communicating artery aneurysm 19 8 24 51
Posterior communicating artery aneurysm 21 3 7 31
Middle cerebral artery aneurysm 8 3 10 21
Internal carotid artery aneurysm 8 3 8 19
Vertebral artery 4 1 3 8
Othersη 16 3 7 26
Multiple sites (N = 12) 6 1 5 12
Diameter of aneurysm (mm)Ф 0.75 ± 0.20 0.71 ± 0.25 0.67 ± 0.32 0.68 ± 0.31
Shape of aneurysmЄ
Pouch 54 17 52 133
Lobulation 13 3 8 24
Fusiform 9 2 1 12
dissection 4 0 2 6
Wide neck 2 0 1 3
η= The other locations of aneurysms included the superior cerebellar artery aneurysm in four,, posterior inferior cerebellar artery aneurysm in four, anterior
cerebral artery aneurysm in four, pericallosal artery aneurysm in three, posterior cerebral artery aneurysm in four, ophthalmic artery in one, basilar artery aneurysm
in five, and anterior inferior cerebellar artery aneurysm in one.
Ф= Indicates the maximum diameter of the aneurysm if at least two aneurysms are found.
Є= Indicates the largest aneurysm if at least two aneurysms are found.
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Table 4 Risk factors of shunt-dependent hydrocephalus in aneurysmal SAH patients without hydrocephalus upon






P value OR 95% CI
Sex (male/female) 20/51 3/12 0.384 0.638 0.163-2.501
Mean age at onset 52.92 ± 11.85 57.93 ± 12.66 0.146
Mean blood pressure on presentation
Mean Systolic Blood pressure (mmHg) 144.59 ± 22.92 148.13± 24.77 0.593
Mean diastolic Blood pressure (mmHg) 81.84 ± 12.734 78.07 ± 14.67 0.312
Mean GCS on presentation 13.17 ± 2.82 10.87 ± 4.17 0.01
Mean modified Fisher SAH grade on presentation 2.44 ± 0.80 2.93 ± 0.96 0.039
Mean WFNS grade on presentation 2.07 ± 1.20 3.00 ± 1.60 0.012
Mean Hospitalization days 24.13 ± 21.50 36.46 ± 20.24 0.0.045
Neuroimaging findings
Rebleeding of aneurysm 4 2 0.280 2.577 0.427-15.563
Intraventricular hemorrhage on admission 5 6 0.003 8.8 2.223-34.842
Intracerebral hemorrhage on admission 12 3 0.72 1.229 0.3-5.301
Underlying diseases
Hypertension 27 6 1.0 1.086 0.348-3.393
Atrial fibrillation 1 0 1.0 0.824 0.746-0.909
Coronary artery diseases 5 1 1.0 0.943 0.102-8.708
Diabetes mellitus 4 3 0.098 4.188 0.83-21.12
End stage renal diseases 2 0 1.0 0.821 0.743-0.908
Other complications following aneurysmal SAH
Cerebral infarction
Symptomatic vasospasm 10 2 1.0 0.938 0.184-4.799
Seizure 9 5 0.063 3.444 0.957-12.40
Diabetes inspidus 0 2 0.029 0.155 0.094-0.255
Hyponatremia 5 2 0.60 2.031 0.355-11.62
Shunt infection 1 1 0.32 5.0 0.295-84.776
Postoperative intracerebral hemorrhage 5 5 0.013 6.6 1.617-26.945
Arrhythmia 1 1 0.320 5.0 0.295-84.776
Outcome
Mean Hospitalization days 24.13 ± 21.50 36.47 ± 20.24 0.0452
Mean GOS at discharge 3.86 ± 1.16 2.93 ± 1.03 0.014
Mean GOS after more than 18 months of follow-up 4.21 ± 1.19 3.33 ± 1.40 0.211
Abbreviations: N, number of cases; OR, odds ratio; CI, confidence interval; SAH, sub-arachnoid hemorrhage; GCS, Glasgow Outcome Scale; GOS, Glasgow Outcome
Scale; WFNS, World Federation of Neurosurgical Societies.
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[3,6] and the largest study [5].
The present study examined the risk factors and out-
come of shunt-dependent hydrocephalus in aneurysmal
SAH patients and produced two major findings. First, the
presence of intra-ventricular hemorrhage, lower mean
score of Glasgow Coma Scale, higher mean scores of both
the modified Fisher SAH grade and the World Federation
of Neurosurgical grade on admission, and complications
with post-operative intra-cerebral hemorrhage are signifi-
cant risk factors for shunt-dependent hydrocephalus inpatients without hydrocephalus on admission. Second,
shunt-dependent hydrocephalus patients have worse
short- and long-term outcomes and longer duration of
hospitalization.
For research on the risk factors and outcomes of shunt-
dependent hydrocephalus, most large studies have focused
on acute or chronic hydrocephalus together, [2,3,6]. Very
few have examined both clinical features and outcomes
for acute and subsequent hydrocephalus, respectively [4].
The pathogenesis of acute hydrocephalus is thought to re-
sult from blockage of CSF flow, producing a pressure
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whereas the pathogenesis of chronic hydrocephalus
involves arachnoid adhesions formed as a result of menin-
geal reaction to blood products, impairing CSF absorption
at the basal cisterns [15,16].
The presence of hydrocephalus does not always lead
to the development of shunt dependency although it is a
strong predictor of such, as noted in previous studies
[17,18] and in the current study. The data here demon-
strates that 39% of patients with acute hydrocephalus on
admission and 50% of those with subsequent hydroceph-
alus have undergone permanent shunting procedures.
Furthermore, there is evidence in literature suggesting
that aggressive external ventricular drainage significantly
reduces the need for permanent shunting among these
patients [19]. Although the effect of temporary ventricu-
lostomy placement on the development of hydroceph-
alus is not studied, its effects on the outcome of
hydrocephalus may also be considered in future studies.
Several studies demonstrate a strong relationship be-
tween poor levels of consciousness on admission and
hydrocephalus [5,7]. Both acute and subsequent hydro-
cephalus cases also have similar results. Some studies
show that the amount of blood in the sub-arachnoid
space has special significance [5,7] while the current
study demonstrates higher mean modified Fisher SAH
grade on presentation in patients who have shunt-
dependent hydrocephalus. The effect of intra-ventricular
hemorrhage on the development of hydrocephalus is
also well established [5,7]. Some authors suggest that the
presence of blood clots and high CSF viscosity can lead
to an obstructive form of hydrocephalus and early CSF
circulation disturbances [20,21]. In the current series,
intra-ventricular hemorrhage is a significant risk factor
for the development of shunt-dependent hydrocephalus
in patients with aneurysmal SAH but without hydro-
cephalus on admission.
The outcomes of hydrocephalus have been extensively
studied. Hydrocephalus can result in long-term cognitive
decline and the development of psycho-organic disor-
ders [22,23]. This study demonstrates the worst short-
term outcome and longest duration of hospitalization in
patients with subsequent hydrocephalus, and the prog-
nosis is also worst after 1.5 years of follow-up. Worse
short- and long-term outcomes and longer duration of
hospitalization are also noted in shunt-dependent hydro-
cephalus patients.
The current study has several limitations. First, it is a
retrospective analysis and therefore subject to bias of
unmeasured factors. Second, patients who were coma-
tose or considered unlikely to survive for more than one
week and had pre-existing neurologic deficits have been
excluded. Third, hydrocephalus can occur in both the
acute stage and later stages during treatment. Thefindings may underestimate the “true” frequency of
hydrocephalus in asymptomatic patients. Thus, there is
continued uncertainty in assessing the incidence of
hydrocephalus after aneurysmal SAH in non-selected
patients.
Conclusions
The presence of intra-ventricular hemorrhage, lower
mean score of Glasgow Coma Scale, and higher mean
scores of the modified Fisher SAH and World Feder-
ation of Neurosurgical grading on admission imply risks
of shunt-dependent hydrocephalus in patients without
hydrocephalus on admission. These patients also have
worse short- and long-term outcomes and longer
hospitalization. More prospective multi-center investiga-
tions evaluating the role of hydrocephalus on outcome
of aneurysmal SAH and timing of surgical intervention
on this specific group of patients are warranted. Despite
the high proportion of disability during the acute stage,
adequate treatment of neurologic complications is essen-
tial for improving therapeutic outcomes.
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